Litifilimab improves symptom burden for patients with systemic lupus erythematosus
1. Litifilimab was associated with a reduction in the number of swollen and tender joints in...
Read MoreSep 13, 2022
1. Litifilimab was associated with a reduction in the number of swollen and tender joints in...
Read MoreSep 13, 2022
1. Early rhythm control for atrial fibrillation (AF) was associated with a significantly reduced...
Read MoreSep 11, 2022
1. While patients with Roux-en-Y Gastric Bypass had increased weight loss and higher type 2...
Read MoreSep 11, 2022
1. Premature mortality was common amongst homeless older adults in the United States. 2. Factors...
Read MoreSep 9, 2022
1. At week 16, average neuropathic pain score decreased for all three treatment groups. 2. Pain...
Read MoreSep 9, 2022
1. Frailty status upon admission to intermediate care was a strong predictor of mortality. ...
Read MoreSep 9, 2022
1. Regular proton pump inhibitor (PPI) use contributed to an increased incidence for all-caused...
Read MoreSep 9, 2022
1. For solid organ transplant recipients with symptomatic COVID-19, factors associated with...
Read MoreSep 9, 2022
1. In this retrospective study, traumatic brain injury in any capacity amongst United States army...
Read MoreSep 9, 2022
1. Nonnormative eating behaviors and eating disorders are common in patients seeking bariatric...
Read MoreSep 6, 2022
1. Patients in the surgical reconstruction group demonstrated improved knee function at 18 months....
Read MoreSep 6, 2022
1. In this prospective cohort study, participants with elevated N-terminal pro-B-type natriuretic...
Read MoreSep 6, 2022
1. Fractional flow reserve (FFR) guidance for percutaneous coronary intervention (PCI) was...
Read MoreSep 6, 2022
1. Four bedaquiline-pretomanid-linezolid treatment groups had a favorable outcome for the...
Read MoreSep 6, 2022
1. Patients with diabetes and high polygenic risk scores are at an increased risk of developing...
Read MoreSep 6, 2022
1. In a very large retrospective cohort of hospitalized pediatric patients, the incidence of C....
Read MoreSep 6, 2022
1. Dolutegravir is associated with greater viral suppression at birth for human immunodeficiency...
Read MoreSep 6, 2022
1. Erlotinib showed an overall survival benefit and improved 5-year survival rates when compared...
Read MoreSep 6, 2022
1. Median progression-free survival was longer in the SG group than in the chemotherapy group. 2....
Read MoreSep 6, 2022
1. A higher physical function among community-dwelling older adults was associated with a...
Read More